Onsdag 28 Oktober | 18:10:59 Europe / Stockholm

All ägardata du vill ha finns i Holdings!

Acarix - Glimpsing the West

2021-10-04 10:15:00

Redeye reviews its assessment of Acarix, acknowledging the clinical and regulatory progress for the CADScor device and the catalysts ahead in the form of acquired reimbursement, high-volume orders, and establishment in the US market. We hike our fair value range as our reassessment suggests a more optimistic take on the case.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/